Full Press Release Details
BridgeBio Pharma Secures Up To $1.25 Billion Of Capital From Blue Owl And CPP Investments To Accelerate Commercial Launch.
BBIO
BridgeBio Pharma Secures Up To $1.25 Billion Of Capital From Blue Owl And CPP Investments To Accelerate Commercial Launch
Key Takeaway: BridgeBio Pharma Secures Up To $1.25 Billion Of Capital From Blue Owl And CPP Investments To Accelerate Commercial Launch